Targeted Nanoparticles for Pediatric Leukemia Therapy

The two major forms of leukemia, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), account for about one-third of the malignancies diagnosed in children. Despite the marked successes in ALL and AML treatment, concerns remain regarding the occurrence of resistant disease in subsets...

Descripción completa

Detalles Bibliográficos
Autores principales: Basha, Riyaz, Sabnis, Nirupama, Heym, Kenneth, Bowman, W. Paul, Lacko, Andras G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026702/
https://www.ncbi.nlm.nih.gov/pubmed/24860784
http://dx.doi.org/10.3389/fonc.2014.00101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026702/
https://www.ncbi.nlm.nih.gov/pubmed/24860784
http://dx.doi.org/10.3389/fonc.2014.00101

Ejemplares similares